Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;77(6):2004-2013.
doi: 10.1161/HYPERTENSIONAHA.120.16534. Epub 2021 Apr 5.

Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses

Affiliations

Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses

Rainer Malik et al. Hypertension. 2021 Jun.

Abstract

[Figure: see text].

Keywords: blood pressure; coronary artery disease; hypertension; primary prevention; stroke.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes. Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes: (A) all incident cardiovascular disease (CVD) events, (B) incident coronary artery disease (CAD), and (C) incident stroke. Displayed on the x axis are SBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a population mean SBP value of 136.5 mm Hg. Gray lines depict the 95% CI. Fractional polynomial test is a goodness-of-fit test assessing whether any improvement of fit using a nonlinear function to model the data compared with a linear function is greater than expected due to chance alone.
Figure 2.
Figure 2.
Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes. Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes: (A) all incident cardiovascular disease (CVD) events, (B) incident coronary artery disease (CAD), and (C) incident stroke. Displayed on the x axis are DBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a population mean DBP value of 81.8 mm Hg. Gray lines depict the 95% CI.
Figure 3.
Figure 3.
Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes split by sex. Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes split by sex: (A) all incident cardiovascular disease (CVD) events in men, (B) incident coronary artery disease (CAD) in males, and (C) incident stroke in men. D–F, Equivalent analyses in women. Displayed on the x axis are SBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a mean SBP value of 136.5 mm Hg. Gray lines depict the 95% CI.
Figure 4.
Figure 4.
Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes split by sex. Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes split by sex: (A) all incident cardiovascular disease (CVD) events in men, (B) incident coronary artery disease (CAD) in men, and (C) incident stroke in men. D–F, Equivalent analyses in women. Displayed on the x axis are DBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a mean DBP value of 81.8 mm Hg. Gray lines depict the 95% CI.

Similar articles

Cited by

References

    1. NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. doi: 10.1016/S0140-6736(16)31919-5 - PMC - PubMed
    1. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, et al. . Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795–808. doi: 10.1016/S0140-6736(19)32008-2 - PMC - PubMed
    1. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967. doi: 10.1016/S0140-6736(15)01225-8 - PubMed
    1. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. . 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e563–e595. doi: 10.1161/CIR.0000000000000677 - PMC - PubMed
    1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, et al. ; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–2381. doi: 10.1093/eurheartj/ehw106 - PMC - PubMed

Publication types